PAVmed (PAVM) Income from Continuing Operations (2016 - 2025)
PAVmed's quarterly Income from Continuing Operations came in at 2757000.0 in Q4 2025, down 341.42% year-on-year from 1142000.0 in Q4 2024, and up 54.13% quarter-over-quarter from 6011000.0 in Q3 2025.
PAVmed has reported Income from Continuing Operations for 10 years, with the latest figure at 2757000.0 in Q4 2025.
- For the quarter ending Q4 2025, Income from Continuing Operations fell 341.42% year-over-year to 2757000.0; the trailing twelve-month figure through Dec 2025 stood at 2469000.0 (up 95.03% YoY), and the FY2025 full-year result was 2469000.0, down 108.69% from the prior year.
- Income from Continuing Operations for Q4 2025 stood at 2757000.0, up from 6011000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 18623000.0 in Q1 2025, with the low at 29932000.0 in Q3 2022.
- Average Income from Continuing Operations over 5 years is 14388526.32, with a median of 17408000.0 recorded in 2023.
- Peak annual rise in Income from Continuing Operations reached 200.6% in 2025, while the deepest fall reached 341.42% in 2025.
- Tracing PAVM's Income from Continuing Operations over 5 years: stood at 19679000.0 in 2021, then fell by 24.86% to 24572000.0 in 2022, then grew by 29.16% to 17408000.0 in 2023, then soared by 106.56% to 1142000.0 in 2024, then slumped by 341.42% to 2757000.0 in 2025.
- The last three Income from Continuing Operations figures came in at 2757000.0 (Q4 2025), 6011000.0 (Q3 2025), and 12324000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | -2.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.76 Mn |
| Sep 30, 2025 | -6.01 Mn |
| Jun 30, 2025 | -12.32 Mn |
| Mar 31, 2025 | 18.62 Mn |
| Dec 31, 2024 | 1.14 Mn |
| Jun 30, 2024 | -14.91 Mn |
| Mar 31, 2024 | -18.51 Mn |
| Dec 31, 2023 | -17.41 Mn |
| Sep 30, 2023 | -21.75 Mn |
| Jun 30, 2023 | -17.89 Mn |
| Mar 31, 2023 | -22.21 Mn |
| Dec 31, 2022 | -24.57 Mn |
| Sep 30, 2022 | -29.93 Mn |
| Jun 30, 2022 | -29.10 Mn |
| Mar 31, 2022 | -19.63 Mn |
| Dec 31, 2021 | -19.68 Mn |
| Sep 30, 2021 | -13.67 Mn |
| Jun 30, 2021 | -12.67 Mn |
| Mar 31, 2021 | -10.11 Mn |
| Dec 31, 2020 | -9.26 Mn |
| Sep 30, 2020 | -5.87 Mn |
| Jun 30, 2020 | -5.84 Mn |
| Mar 31, 2020 | -14.91 Mn |
| Dec 31, 2019 | -6.55 Mn |
| Sep 30, 2019 | -3.27 Mn |
| Jun 30, 2019 | -3.74 Mn |
| Mar 31, 2019 | -3.70 Mn |
| Dec 31, 2018 | -6.92 Mn |
| Sep 30, 2018 | -3.28 Mn |
| Jun 30, 2018 | -5.15 Mn |
| Mar 31, 2018 | -2.83 Mn |
| Dec 31, 2017 | 869,844.00 |
| Sep 30, 2017 | -5.13 Mn |
| Jun 30, 2017 | -989,707.00 |
| Mar 31, 2017 | -4.27 Mn |
| Dec 31, 2016 | -1.71 Mn |
| Sep 30, 2016 | -1.93 Mn |
| Jun 30, 2016 | -1.31 Mn |
| Mar 31, 2016 | -696,880.00 |